The Effect of Edaravone on MAPKs Signal Pathway Associated with Aβ\25-35 Treatment in PC12 Cells

ZHANG Gui-lian, GUO Ying-ying, ZHANG Lei. et al

Abstract

To explore whether edaravone protects cells damage via mitogen-activated protein kinases (MAPKs) signal pathway, and which procedure of p38 be affected so as to add theories for AD pathogenesis and treatments. Methods According to different drugs treated, PC12 cells \in vitro were divided into four groups. Negative control group: cells were treated with media alone. AD model group: cells were treated with 30 μmol/L Aβ\25-35. Inhibitor control group: cells were treated with 10 μmol/L SB203580 〔p38 mitogen-activated protein kinase (p38) inhibitor〕, 10 μmol/L SP600125 〔c-Jun NH2 terminal kinase (JNK) inhibitor〕, or 10 μmol/L PD98059 extracelular signal regulated kinase (ERK) inhibitor〕. Low-dose, middle-dose and high-dose edaravone group: cells plated for 24 hours treated with 30 μmol/L Aβ\25-35 and co-treated with 20, 40, 80 μmol/L edaravone 3 hours, respectively. The morphology of the treated cells were observed, the p-p38, p-JNK and p-ERK proteins in each group were tested by the Western blot. The p38 mRNA were tested in each group above (only add SB203580 10 μmol/L in third group) by the real time PCR. Results ① The p-p38 protein was significantly increased in model control group compared with that in negative control group (\P\P<0.05) when compared with that in model control group.

 

Keywords: Alzheimer disease, Amyloid beta, Edaravone, MAPKsPC12 cells 

 

Full Text:

PDF


References


Zhang CL, Zhang WG, Du Yun, et al. Edaravone ameliorates oxidative damage associated with А{3г5-з5 treatment in PCI2 cells. J Mol Neurosci,2013;50(3) ;494-503.

Lenka M. Alaina JA. Targeting p38 МАРК pathway for the treatment of Alzheimer's disease. Neuropharmacology, 2010; 58(3):561-568.

Shimazaki H, Watanabe K, Veeraveedu PT, et al. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis. Free Radic Res,2010;44(9) : 1082-1090.

Zhao ZY. Luan P. Huang SX. etal. Edaravone protects HT22 neurons from Ни (-induced apoptosis by inhibiting the МАРК signaling pathway. CMS Neurosci Ther.2013; 19(3) : 163-169.

Li CT, Zhang WP, Lu YB. et al. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PCI2 cells. J Neurosci Res,2009;87(4) ;991-1001.

Liu XY, Yao LL. Chen YJ, et at. Survivin is involved in the anti-apoptotic effect of edaravone in PCI2 cells. Mol Cell Biochem.2009;327(1-2):21-28.

Giovannini MO, Bellucci FCA, Melani C. et al. Casamenti. Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease. Neuroscience, 2008; 153(3):618-633.

Morishima Y, Gotoh Y. Zieg J, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N- terminal kinase pathway and the induction of Fas ligand. J Neurosci, 2001; 21 (19): 7551 -60.

Shoji M. Iwakami N. Takeuchi S. et al. JNK activation is associated with intracellular beta-amyloid accumulation. Brain Res Mol Brain Res,2000;85( 1-2) :221-33.

Zhu X. Mei M, Lee HG, et al. P38 activation mediates amyloid-p cytotoxicity. Neurochem Res. 2005; 30 ( 6-7 ): 791- 796.

Savage MJ, Lin YG, Ciallella JR. et al. Activation of c-Jun N- terminal kinase and p38 in an Alzheimer ’ s disease model is associated with amyloid deposition. J Neurosci, 2002; 22 ( 9 ): 3376-3385.

Zhu X, RottkampCA, Boux H, et al. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle- related events in Alzheimer disease. J Neuropathol Exp Neurol, 2000; 59(10); 880-888.

Gum RJ, McLaughlin MM, Kumar S, et al. Acquisition of sensitivity of stress-activated protein kinases to the P38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem, 1998; 273 ( 25): 15605-15610.


Refbacks

  • There are currently no refbacks.